tiprankstipranks
Trending News
More News >
Inmune Bio Inc (INMB)
NASDAQ:INMB

Inmune Bio (INMB) Revenue

Compare
702 Followers

Inmune Bio Revenue

Inmune Bio had a revenue of 0.00 in the quarter ending Sep 30, 2024, with ―. This bring the company's revenue in the last twelve months to 42.00K, Increased -50.59%. In the fiscal year ending Dec 31, 2024, Inmune Bio had annual revenue of 14.00K with -90.97% growth.
Revenue (ttm)
42.00K
Revenue Growth
-90.97%
P/S Ratio
12102.55
Revenue/Employee
$1,077
Employees
13
Market Cap
$169.44M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
14.00K-141.00K-90.97%
Dec 31, 2023
155.00K-219.00K-58.56%
Dec 31, 2022
374.00K193.00K+106.63%
Dec 31, 2021
181.00K170.08K+1,558.12%
Dec 31, 2020
10.92K-77.68M-99.99%
Dec 31, 2019
77.69M+∞%
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
Dec 31, 2015
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis